Resiliency Through Azithromycin for Children (REACH), Côte d'Ivoire (REACH)
REACH Côte d'Ivoire: Feasibility and Acceptability of Integrating Mass Distribution of Azithromycin to Children 1-11 Months Into a Trachoma Mass Drug Administration Campaign to Reduce Child Mortality
Sponsor: FHI 360
Listed as NCT04617626, this NA trial focuses on Azithromycin and Child Mortality and remains completed. Sponsored by FHI 360, it has been updated 7 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
-
Mar 2021 — Sep 2021 [monthly]
Completed NA
Status: Not Yet Recruiting → Completed
▶ Show 2 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Nov 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- FHI 360
- National Program for the Fight Against Neglected Tropical Diseases, Côte d'Ivoire
For direct contact, visit the study record on ClinicalTrials.gov .